In our experience, cholinesterase inhibitors may produce some symptomatic relief to the ocular manifestations of MG, especially ptosis, but rarely result in resolution of symptoms; however, others have noted that >50% of patients improve symptomatically on cholinesterase treatment (10). This evidence concerns the gene BCHE and ptosis.